Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC
不可切除的III期ALK阳性非小细胞肺癌患者接受放化疗后，ALK酪氨酸激酶抑制剂巩固治疗与度伐利尤单抗或观察的比较
期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2024.09.1379
Nassar, Amin H; Jayakrishnan, Ritujith; Feng, Jamie; Shepherd, Frances; Adib, Elio; Cheung, Justin M; Lin, Jessica J; Liu, Yufei; Lin, Steven H; Parikh, Kaushal; Sridhar, Arthi; Shakya, Purnima; Dilling, Thomas J; Kaldas, David; Gray, Jhanelle E; Lobachov, Anastasiya; Bar, Jair; Luders, Heike; Grohe, Christian; Gupta, Shruti; Leal, Ticiana; Fitzgerald, Bailey; Crowley, Fionnuala; Fujiwara, Yu; Marron, Thomas U; Wilgucki, Molly; Reuss, Joshua; Chen, Luxi; Sankar, Kamya; Aredo, Jacqueline V; Neal, Joel W; Wakelee, Heather A; Thummalapalli, Rohit; Yu, Helena; Whitaker, Ryan; Velazquez, Ana; Ragavan, Meera; Cortellini, Alessio; Kwiatkowski, David J; Naqash, Abdul Rafeh; Goldberg, Sarah B; Kim, So Yeon
